Associations between the function of NHE1 and the pathogenesis of depression, such as impaired neurotransmitter release, elevated central inflammation, and hyperactive hypothalamic–pituitary–adrenal (HPA) axis, has been described by recent studies. Here, SLC9A1 is linked to depressive symptom measurement.